Paper9529167
Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells.
Otani A and 3 others. Circ Res, 1998. Cited by 230 papers, by iCite.
Cite this record
ConductScience Library. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Papers, record 9529167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9529167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin II | Major topic |
| Endothelium, Vascular | Major topic |
| Neovascularization, Physiologic | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Growth Factor | Major topic |
| Animals | |
| Aorta | |
| Capillaries | |
| Cattle | |
| Cell Division | |
| Cells, Cultured | |
| Gene Expression | |
| Protein Kinase C | |
| Protein-Tyrosine Kinases | |
| RNA, Messenger | |
| Receptors, Cell Surface | |
| Receptors, Mitogen | |
| Receptors, Vascular Endothelial Growth Factor | |
| Retina | |
| Signal Transduction | |
| Transcription, Genetic |
Source PubMed
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 230 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41301028 | The Involvement of the Peptidergic Systems in Breast Cancer Development. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301028 | PubMed |
| 38347174 | Genetic susceptibility for retinopathy of prematurity and its associated comorbidities. | Pediatr Res | 2024 | https://conductscience.org/library/papers/38347174 | PubMed |
| 36944130 | Internalization of Angiotensin-(1-12) in Adult Retinal Pigment Epithelial-19 Cells. | J Ocul Pharmacol Ther | 2023 | https://conductscience.org/library/papers/36944130 | PubMed |
| 36577381 | Toward structural-omics of the bovine retinal pigment epithelium. | Cell Rep | 2022 | https://conductscience.org/library/papers/36577381 | PubMed |
| 34827169 | Zebrafish Model to Study Angiotensin II-Mediated Pathophysiology. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34827169 | PubMed |
| 34439486 | Angiotensin II Induces Oxidative Stress and Endothelial Dysfunction in Mouse Ophthalmic Arteries via Involvement of AT1 Receptors and NOX2. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34439486 | PubMed |
| 34177375 | Lack of relationship between Alu repetitive elements in angiotensin converting enzyme and the severity of diabetic retinopathy. | J Med Biochem | 2021 | https://conductscience.org/library/papers/34177375 | PubMed |
| 30126320 | Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril. | J Renin Angiotensin Aldosterone Syst | 2018 | https://conductscience.org/library/papers/30126320 | PubMed |
| 29445185 | Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression. | Sci Rep | 2018 | https://conductscience.org/library/papers/29445185 | PubMed |
| 28979999 | Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. | Invest Ophthalmol Vis Sci | 2017 | https://conductscience.org/library/papers/28979999 | PubMed |
| 28761566 | Many Faces of Renin-angiotensin System - Focus on Eye. | Open Ophthalmol J | 2017 | https://conductscience.org/library/papers/28761566 | PubMed |
| 28730079 | Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats. | Int J Ophthalmol | 2017 | https://conductscience.org/library/papers/28730079 | PubMed |
| 28403787 | Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy. | Curr Med Chem | 2017 | https://conductscience.org/library/papers/28403787 | PubMed |
| 28367520 | Therapeutic targets of renin-angiotensin system in ocular disorders. | J Curr Ophthalmol | 2017 | https://conductscience.org/library/papers/28367520 | PubMed |
| 28304186 | miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan. | J Renin Angiotensin Aldosterone Syst | 2016 | https://conductscience.org/library/papers/28304186 | PubMed |
| 27381670 | Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia. | Sci Rep | 2016 | https://conductscience.org/library/papers/27381670 | PubMed |
| 26658948 | Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy. | PLoS One | 2015 | https://conductscience.org/library/papers/26658948 | PubMed |
| 25802486 | MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells. | Mol Vis | 2015 | https://conductscience.org/library/papers/25802486 | PubMed |
| 25276298 | Angiotensin II-related hypertension and eye diseases. | World J Cardiol | 2014 | https://conductscience.org/library/papers/25276298 | PubMed |
| 24966660 | Influence of subretinal fluid in advanced stage retinopathy of prematurity on proangiogenic response and cell proliferation. | Mol Vis | 2014 | https://conductscience.org/library/papers/24966660 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9529167
GET https://conductscience.org/api/papers/v1/9529167/cited_by?page=2